NVIDIA is a publicly traded company in the Technology sector. As a major technology firm, this company faces both opportunities and risks from Congressional action on AI regulation, data privacy legislation, semiconductor policy, and antitrust enforcement. HillSignal is tracking 21 active Congressional signals mentioning NVIDIA, including 21 bills. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.
HR8036 is a procedural bill that does not authorize any funding and is awaiting floor action. It expands interagency authority to propose export control rule changes and mandates a State Department review of China's military-civil fusion strategy. The primary market implication is the potential for future export restrictions on semiconductor equipment and AI chips to China, which poses a downside risk to AMAT, KLAC, LRCX, and NVDA. Defense primes (LMT, NOC, RTX, BA) see no near-term direct impact.
HR8287 is a procedural bill requiring a one-year study on existing semiconductor export controls. It authorizes zero spending and changes no regulations. Neutral market impact with no direct effect on covered semiconductor companies.
The SCALE Act (HR8306) codifies existing AI chip export restrictions into a predictable annual review cycle. For $NVDA, $AMD, and $SMCI, this removes sudden ban risk but locks out China revenue growth. NVDA at $200.67 sits near its 52-week high of $216.83; the stock is down 6.6% from its April 28 close of $213.17. Market is pricing in limited near-term disruption from this early-stage bill.
HR8283, the 'Deterring American AI Model Theft Act of 2026', is an early-stage bill expressing a sense of Congress regarding foreign extraction of closed-source AI model weights. It authorizes no appropriations, creates no compliance obligations for public companies, and remains in committee awaiting floor action. Near-zero market impact.
HR8169, the Export Control Enforcement and Enhancement Act, passed House Foreign Affairs 44-0 on April 22, 2026. It mandates a 30-45 day vote on Entity List changes, dramatically accelerating China tech sanctions. China-exposed semiconductor names (NVDA, QCOM, ASML) face immediate revenue risk, while domestic foundry INTC benefits as the only geopolitically safe advanced node option. The bill awaits full House floor action.
HR8031 (GUARDRAILS Act) repeals the December 2025 AI Executive Order, removing the federal policy framework for AI development. This creates near-term regulatory uncertainty for AI developers and hardware suppliers like NVDA. The bill is in early legislative stages (referred to committee) so market impact is muted for now, but the structural signal is negative for AI investment visibility.
The Future of AI Innovation Act sets policy direction for increased federal AI hardware, semiconductor, and cloud procurement without direct appropriations. NVDA, INTC, and AMZN are structurally positioned to capture incremental government AI spending. NVDA has $201.57 with +15.58% 30-day momentum; INTC surged +112.62% to $93.84; AMZN is at $259.85 with +24.77% 30-day gain.
The OPT Fair Tax Act (S. 2940) is an early-stage Senate bill that would impose FICA and Social Security payroll taxes on F-1 visa holders working under Optional Practical Training. Currently stalled in committee since September 2025, the bill carries no immediate market impact. If enacted, it would raise labor costs for major US tech employers by ~7.65% per OPT employee, but the total cost is negligible relative to revenue. No publicly traded company faces material earnings exposure.
HR7434 is an early-stage authorization bill establishing a prize program for AI R&D with no direct appropriations, no regulatory mandates, and no identifiable near-term revenue impact for any public company. No actionable ticker exposure exists at this stage.
The AI Grand Challenges Act of 2026 is an early-stage authorization-only bill that creates a prize competition program at NSF but appropriates zero funds. With minimal cosponsors, a single committee referral, and no spending mechanism, it has no near-term market impact.
Stop Stealing our Chips Act (HR6322) establishes a whistleblower program for export control violations on advanced AI chips but allocates no new funding and imposes no new restrictions. Compliance costs increase marginally for affected chip exporters, with no immediate financial gains or losses for major semiconductor companies.
HR1062 permanently locks in higher FDII and GILTI deductions for US multinationals, preventing a ~3.3 ppt effective tax rate increase on foreign IP income scheduled for 2026. This directly boosts after-tax net income for companies with large international revenue streams, including MSFT, AAPL, GOOGL, AMZN, NVDA, JNJ, PFE, KO, and PG. The bill is in early committee stage — structural impact is contingent on passage through the 119th Congress.
S.3854 is an early-stage, unfunded authorization bill that creates no immediate market impact. It establishes a procurement framework for HPC and cloud services at DOE-NOAA, structurally benefiting NVIDIA (GPUs), HPE (Cray supercomputers), and AWS (cloud compute). The bill is in referral stage with only 2 actions since Feb 2026 — a long legislative path remains.
The AI OVERWATCH Act (HR6875) proposes mandatory export licenses for advanced integrated circuits to China and other countries of concern, directly targeting AI-chip heavyweights NVDA, AMD, and INTC. The bill is in early legislative stages (referred to committee), but its regulatory signal has already been partially priced into the sector. Real market data shows NVDA at $208.27 near its 52-week high of $216.83; AMD at $333.98 up 64% in 30 days; INTC at $92.92 up 111% in 30 days—these recent rallies reflect broader AI optimism, not this bill, which remains a headwind if it advances.
HR1990, the American Innovation and R&D Competitiveness Act, would restore immediate expensing for R&D costs, reversing the 2022 tax code change that required 5/15-year amortization. This is an early-stage bill referred to Ways and Means with 81 cosponsors, but if enacted, it would provide a direct 21% tax-rate cash flow benefit annually to every R&D-intensive US company. The largest absolute beneficiaries are mega-cap tech and pharma firms with $10B+ annual R&D budgets.
HR6996, the Full AI Stack Export Promotion Act, reported out of House Foreign Affairs on a 37-7 vote, reduces regulatory barriers for U.S. AI chip, cloud, and infrastructure exports to allies. Real market data shows broad AI infrastructure momentum: AMD surging 72% in 30 days, Intel up 130% on broader restructuring, NVDA trading at $209 near its 52-week high. This bill structurally favors U.S. AI hardware and cloud providers by creating a formal export facilitation mechanism for allied nations. No explicit funding — it's a regulatory and policy shift, not an appropriations bill.
The AI-Related Job Impacts Clarity Act (S3108) is an early-stage Senate bill requiring quarterly disclosures of AI-driven job changes. It imposes new compliance costs on major AI investors like Microsoft, Alphabet, Amazon, NVIDIA, and Meta without allocating any funding. Market impact is currently low given the bill's procedural status, but the transparency risk is real for AI-heavy companies.
HR2321 (United States Leadership in Immersive Technology Act of 2025) is an early-stage bill referred to committee in March 2025. It establishes a purely advisory panel with no funding authorizations or appropriations, creating zero near-term financial impact on any public company.
HR7509 is an early-stage bill that would deny tax benefits to firms using foreign adversary-controlled technology. At present, it has been referred to the House Ways and Means Committee with no further action. Market impact is minimal — the bill faces a long legislative path and funding mechanism definition is absent.
S.3957 (NSF AI Education Act of 2026) is an early-stage bill authorizing NSF to create AI education programs but provides zero direct funding or procurement mandates. With only two sponsors, a single referral to committee, and no appropriations, its near-term market impact is negligible. NVDA remains driven by real earnings and private capex, not procedural authorization bills.
The SELF DRIVE Act (HR7390) has advanced out of subcommittee on a strict party-line 12-11 vote, but its path to law is narrow. The bill creates a federal preemption framework for AV safety standards—zero authorized funding. Beneficiary stocks have rallied 5-28% over the last 30 days on anticipation. GOOGL, NVDA, and QCOM are the clearest structural winners due to direct product exposure (Waymo, DRIVE Orin, Snapdragon Ride). INTC's +130% gain is explicitly unrelated to this bill. The 1-vote margin in subcommittee signals that passage through the full Energy & Commerce Committee and the House floor is far from guaranteed.